Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study H Naci, JPA Ioannidis Bmj 347, f5577, 2013 | 947 | 2013 |
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals … C Davis, H Naci, E Gurpinar, E Poplavska, A Pinto, A Aggarwal bmj 359, 2017 | 649 | 2017 |
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers JP Jansen, H Naci BMC medicine 11, 1-8, 2013 | 563 | 2013 |
From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management E Mossialos, E Courtin, H Naci, S Benrimoj, M Bouvy, K Farris, P Noyce, ... Health policy 119 (5), 628-639, 2015 | 503 | 2015 |
Distribution of road traffic deaths by road user group: a global comparison H Naci, D Chisholm, TD Baker Injury prevention 15 (1), 55-59, 2009 | 452 | 2009 |
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials H Naci, J Brugts, T Ades Circulation: Cardiovascular Quality and Outcomes 6 (4), 390-399, 2013 | 403 | 2013 |
How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on … H Naci, M Salcher-Konrad, S Dias, MR Blum, SA Sahoo, D Nunan, ... British journal of sports medicine 53 (14), 859-869, 2019 | 312 | 2019 |
Economic burden of multiple sclerosis: a systematic review of the literature H Naci, R Fleurence, J Birt, A Duhig Pharmacoeconomics 28, 363-379, 2010 | 280 | 2010 |
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and … H Naci, JJ Brugts, R Fleurence, B Tsoi, H Toor, AE Ades european Journal of preventive Cardiology 20 (4), 641-657, 2013 | 233 | 2013 |
Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US Food and Drug Administration H Naci, KR Smalley, AS Kesselheim Jama 318 (7), 626-636, 2017 | 186 | 2017 |
Evaluation of Wellness Determinants and Interventions by Citizen Scientists H Naci, JPA Ioannidis JAMA 350, h1323, 2015 | 170 | 2015 |
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional … H Naci, C Davis, J Savović, JPT Higgins, JAC Sterne, B Gyawali, ... bmj 366, 2019 | 129 | 2019 |
Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? E Mossialos, H Naci, E Courtin Health policy 111 (2), 135-148, 2013 | 128 | 2013 |
Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study D Chisholm, H Naci, AA Hyder, NT Tran, M Peden Bmj 344, 2012 | 109 | 2012 |
Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies N Aung, S Doimo, F Ricci, MM Sanghvi, C Pedrosa, SP Woodbridge, ... Circulation: Cardiovascular Imaging 13 (1), e009712, 2020 | 101 | 2020 |
How good is “evidence” from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs? H Naci, JPA Ioannidis Annual review of pharmacology and toxicology 55, 169-189, 2015 | 92 | 2015 |
The critical role of observational evidence in comparative effectiveness research RL Fleurence, H Naci, JP Jansen Health Affairs 29 (10), 1826-1833, 2010 | 87 | 2010 |
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology N Jackson, D Atar, M Borentain, G Breithardt, M van Eickels, M Endres, ... European heart journal 37 (9), 747-754, 2016 | 83 | 2016 |
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials H Naci, JJ Brugts, R Fleurence, AE Ades European journal of preventive cardiology 20 (4), 658-670, 2013 | 82 | 2013 |
Cost implications of using different ECG criteria for screening young athletes in the United Kingdom H Dhutia, A Malhotra, V Gabus, A Merghani, G Finocchiaro, L Millar, ... Journal of the American College of Cardiology 68 (7), 702-711, 2016 | 81 | 2016 |